Crown Bioscience Launches e-Commerce Platform to Commercialize its Life Science Products
(Thomson Reuters ONE) -
SANTA CLARA, Calif., April 19, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a
wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554)
and a global drug discovery and development services company providing
translational platforms to advance oncology and metabolic disease research, has
launched an e-commerce platform to support the commercialization of its Life
Science products.
The launch follows the recent expansion of CrownBio's Life Science division and
answers the need to accommodate an increasing demand for the Company's products.
CrownBio's clients will now be able to purchase hundreds of products online
across a portfolio consisting of: antibodies for in vivo and in vitro studies,
recombinant proteins and cell lines, immune checkpoint antibodies, and tumor
tissue microarrays.
This digital tool facilitates and accelerates clients' ordering, enabling them
to create online accounts to track the history of their previous orders, save
and share quotations for pending approval, and conveniently process
transactions.
"We have created a digital user-friendly experience. Our platform has been
updated to meet client expectations and provide an improved opportunity to
purchase and deliver products online at CrownBio," commented Debby Saunders,
Executive Director of Life Science Development at CrownBio.
"We remain impressed by the incredible growth and development of every division
at CrownBio," stated Laurie Heilmann, SVP of Global Strategy, Marketing and
Business Development. "In the Life Science sector, I am pleased we could
successfully pivot CrownBio digital engagement efforts with the development of
the e-commerce platform, which will ensure a client friendly, efficient
experience to purchasing our products."
CrownBio's online shop can be accessed from the company website at this
link https://www.crownbio.com/shop.
For more information on CrownBio's commitment to furthering the field of
oncology and metabolic disease drug discovery, visit https://www.crownbio.com.
About Crown Bioscience Inc.
Crown Bioscience is a global drug discovery and development solutions company
providing translational platforms to advance oncology and metabolic disease
research. With an extensive portfolio of relevant models and predictive tools,
Crown Bioscience enables clients to deliver superior clinical candidates.
Media Enquiries:
Jody Barbeau
Crown Bioscience Inc. marketing(at)crownbio.com
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Crown Bioscience Inc. via GlobeNewswire
Datum: 19.04.2017 - 14:00 Uhr
Sprache: Deutsch
News-ID 537063
Anzahl Zeichen: 3168
contact information:
Town:
Santa Clara
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 207 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Crown Bioscience Launches e-Commerce Platform to Commercialize its Life Science Products"
steht unter der journalistisch-redaktionellen Verantwortung von
Crown Bioscience Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
